Inhibiting the Jumonji family: a potential new clinical approach to targeting aberrant epigenetic mechanisms.
Martinez, Elisabeth D
Inhibiting the Jumonji family: a potential new clinical approach to targeting aberrant epigenetic mechanisms. [electronic resource] - Epigenomics Mar 2016 - 313-6 p. digital
Publication Type: Editorial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1750-192X
10.2217/epi.15.115 doi
Enzyme Inhibitors--pharmacology
Epigenesis, Genetic--drug effects
Histone Demethylases--antagonists & inhibitors
Humans
Jumonji Domain-Containing Histone Demethylases--antagonists & inhibitors
Molecular Targeted Therapy--methods
Protein Domains
Inhibiting the Jumonji family: a potential new clinical approach to targeting aberrant epigenetic mechanisms. [electronic resource] - Epigenomics Mar 2016 - 313-6 p. digital
Publication Type: Editorial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1750-192X
10.2217/epi.15.115 doi
Enzyme Inhibitors--pharmacology
Epigenesis, Genetic--drug effects
Histone Demethylases--antagonists & inhibitors
Humans
Jumonji Domain-Containing Histone Demethylases--antagonists & inhibitors
Molecular Targeted Therapy--methods
Protein Domains